Summary:
- This article discusses the progress of a medical device company called CardioValve in the development of a new tricuspid valve system.
- CardioValve has completed the target enrollment for a study on their tricuspid valve system, which is a crucial step towards obtaining CE marking approval for the product in Europe.
- The successful completion of the study enrollment indicates that the tricuspid valve system is progressing well through the clinical development process, bringing it closer to becoming available as a new treatment option for patients with tricuspid valve disorders.